Zydus Lifesciences has informed that it enclosed a copy of press release dated October 13, 2026, titled ‘Zydus and Formycon: FYB206 Becomes First Publicly Announced Keytruda® Biosimilar Accepted for Review by USFDA’.
The above information is a part of company’s filings submitted to BSE.